79398397 - SERB PHARMACEUTICALS

Information

• Trademark
• 79398397

• Source

• Serial Number

  79398397

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  January 15, 2024
  11 months ago

• Transaction Date

  January 03, 2025
  4 days ago

• Status Date

  January 03, 2025
  4 days ago

• Location Date

  January 03, 2025
  4 days ago

• Status Code

  645

• Current Location

  TMEG LAW OFFICE 101

  Employee Name

  DOMBROW, COLLEEN

• Attorney Docket Number

  219151.28

  Attorney Name

  Sherry L. Rollo

  Law Office Assigned Location Code

  L10

• Owners

  • SERB SA

Case File Statements

• DM0000: The mark consists of the wording "SERB PHARMACEUTICALS". The word "SERB" appears above the word "PHARMACEUTICALS". To the left of the wording is a circular shape resembling a donut.
• GS0051: Pharmaceutical preparations, medicines and substances, namely, Pharmaceutical preparations for treating poisonings, overdoses of any type, allergies, snake bites, nuclear radiations, infections, tumors, heart diseases, diagnostic agents, blood diseases, skin diseases, gastric diseases, liver diseases, neurological diseases, ophthalmological diseases, lung diseases, rhumatological diseases, rare diseases; Pharmaceutical preparations for the treatment of snake bite venom; Pharmaceutical preparations for the treatment of digoxin toxicity and/or overdose; Pharmaceutical preparations for the treatment of methotrexate toxicity and/or overdose; Pharmaceutical preparations, namely, potassium iodide, for the treatment of exposure to nuclear radiation; Pharmaceutical preparations for the treatment of cyanide poisoning; Antidotes; veterinary preparations, medicines and substances, namely, veterinary preparations of snake bite venom, veterinary preparations for the treatment of digoxin toxicity and/or overdose, veterinary preparations for the treatment of methotrexate toxicity and/or overdose, veterinary preparations for the treatment of cyanide poisoning; Biological preparations for medical, pharmaceutical and veterinary use, namely, biological preparations for the treatment of cancer;; radioactive substances for medical use; dietetic beverages and foods adapted for medical use; nutritional supplements for medical use; diagnostic preparations for medical or veterinary use; chemical reagents for medical or veterinary use; radiological contrast substances for medical use; herbal tinctures for medical use; surgical implants made of living tissue; medical and veterinary microbial media, namely, cell culture media for medical and veterinary use; cultures of microorganisms for medical or veterinary use; antibiotic preparations; dressings for medical use.
• GS0011: Chemical preparations for scientific use, other than for medical or veterinary use; Chemical substances for scientific use for analyses in laboratories, other than for medical or veterinary use; chemical preparations and substances with or without coloring agents for laboratory analyses, other than for medical or veterinary use; chemical preparations for scientific purposes other than for medical or veterinary use; diagnostic preparations and substances in the nature of chemicals with or without coloring agents other than for medical or veterinary use, namely, chemical diagnostic reagents for industrial purposes; chemical additives with or without coloring agents used in the composition of diagnostic preparations and substances, namely, chemical additives for use in the manufacture of pharmaceuticals; chemical reagents with or without coloring agents, other than for medical or veterinary use, namely, chemical reagents for non-medical purposes; active chemical ingredients for use in the manufacture of pharmaceuticals for the treatment of snake bite venom, the treatment of digoxin toxicity and/or overdose, the treatment of methotrexate toxicity and/or overdose, the treatment of exposure to nuclear radiation and the treatment of cyanide poisoning.
• GS0441: Medical services; medical assistance; veterinary services; consultation with respect to pharmacy, namely, pharmaceutical consultation and clinical trials.
• DS0000: PHARMACEUTICALS
• GS0101: Surgical apparatus and instruments for medical, dental and veterinary use; infusion apparatus for therapeutic use; thermometers for medical use; Artificial implants, namely, implants consisting of artificial materials; stents; Dental prostheses; cardiac pacemakers; lenses in the nature of intraocular prostheses for surgical implantation; Orthopedic articles, namely, medical devices for the prevention and the correction of disorders of the musculoskeletal system affecting bones, joints, muscles, tendons and nerves x-ray apparatus for medical use; Electromagnetic medical diagnostic imaging apparatus; Medical diagnostic instruments for the analysis of body fluids Medical diagnostic equipment, namely, diagnostic penlights for medical purposes
• GS0421: Medical research services; Scientific research for medical use; pharmaceutical diagnostic testing services, namely, testing of pharmaceuticals and clinical trials; Research and development of new products; assessment in scientific and technical fields provided by engineers, namely, consulting in the field of engineering; Appraisals in the fields of science and technology provided by engineers, namely, conducting scientific feasibility studies; scientific research; Technical and scientific studies, namely, conducting scientific feasibility studies

Case File Event Statements

• 6/27/2024 - 6 months ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 7/1/2024 - 6 months ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 7/1/2024 - 6 months ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 8/9/2024 - 5 months ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 8/12/2024 - 4 months ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 8/20/2024 - 4 months ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 8/13/2024 - 4 months ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 8/20/2024 - 4 months ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 9/9/2024 - 4 months ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 12/30/2024 - 8 days ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/30/2024 - 8 days ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/30/2024 - 8 days ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 1/3/2025 - 4 days ago

  15 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 1/3/2025 - 4 days ago

  13 - FINAL REFUSAL WRITTEN Type: CNFR

• 1/3/2025 - 4 days ago

  14 - FINAL REFUSAL E-MAILED Type: GNFR